Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
出版年份 2019 全文链接
标题
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma
作者
关键词
-
出版物
Nature Communications
Volume 10, Issue 1, Pages -
出版商
Springer Nature
发表日期
2019-03-22
DOI
10.1038/s41467-019-09257-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- EWS/ETS-driven Ewing Sarcoma requires BET bromodomain proteins
- (2018) Paradesi Naidu Gollavilli et al. CANCER RESEARCH
- EWS-FLI1 regulates a transcriptional program in cooperation with Foxq1 in mouse Ewing sarcoma
- (2018) Rikuka Shimizu et al. CANCER SCIENCE
- Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma
- (2018) Liang Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BET Bromodomain Proteins Function as Master Transcription Elongation Factors Independent of CDK9 Recruitment
- (2017) Georg E. Winter et al. MOLECULAR CELL
- Is a super-enhancer greater than the sum of its parts?
- (2017) Noah Dukler et al. NATURE GENETICS
- dbCoRC: a database of core transcriptional regulatory circuitries modeled by H3K27ac ChIP-seq signals
- (2017) Moli Huang et al. NUCLEIC ACIDS RESEARCH
- BCL6 promotes glioma and serves as a therapeutic target
- (2017) Liang Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- PAX3–FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability
- (2017) Berkley E. Gryder et al. Cancer Discovery
- Bromodomain inhibitors and cancer therapy: From structures to applications
- (2016) Montserrat Pérez-Salvia et al. Epigenetics
- Models of human core transcriptional regulatory circuitries
- (2016) Violaine Saint-André et al. GENOME RESEARCH
- Efficacy and Safety of Trabectedin or Dacarbazine for Metastatic Liposarcoma or Leiomyosarcoma After Failure of Conventional Chemotherapy: Results of a Phase III Randomized Multicenter Clinical Trial
- (2016) George D. Demetri et al. JOURNAL OF CLINICAL ONCOLOGY
- Near-optimal probabilistic RNA-seq quantification
- (2016) Nicolas L Bray et al. NATURE BIOTECHNOLOGY
- Systematic mapping of functional enhancer–promoter connections with CRISPR interference
- (2016) Charles P. Fulco et al. SCIENCE
- BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma
- (2016) Sudan N. Loganathan et al. Oncotarget
- Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
- (2015) Jing Lu et al. CHEMISTRY & BIOLOGY
- Screen identifies bromodomain protein ZMYND8 in chromatin recognition of transcription-associated DNA damage that promotes homologous recombination
- (2015) Fade Gong et al. GENES & DEVELOPMENT
- Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma
- (2015) Emily Z. Keung et al. JOURNAL OF CLINICAL INVESTIGATION
- Trabectedin monotherapy after standard chemotherapy versus best supportive care in patients with advanced, translocation-related sarcoma: a randomised, open-label, phase 2 study
- (2015) Akira Kawai et al. LANCET ONCOLOGY
- Phthalimide conjugation as a strategy for in vivo target protein degradation
- (2015) G. E. Winter et al. SCIENCE
- Genomic landscape of liposarcoma
- (2015) Deepika Kanojia et al. Oncotarget
- BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells
- (2015) Emma K Baker et al. Scientific Reports
- Epigenome Mapping Reveals Distinct Modes of Gene Regulation and Widespread Enhancer Reprogramming by the Oncogenic Fusion Protein EWS-FLI1
- (2015) Eleni M. Tomazou et al. Cell Reports
- bwtool: a tool for bigWig files
- (2014) Andy Pohl et al. BIOINFORMATICS
- EWS-FLI1 Utilizes Divergent Chromatin Remodeling Mechanisms to Directly Activate or Repress Enhancer Elements in Ewing Sarcoma
- (2014) Nicolò Riggi et al. CANCER CELL
- Browning of human adipocytes requires KLF11 and reprogramming of PPARγ superenhancers
- (2014) Anne Loft et al. GENES & DEVELOPMENT
- Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma
- (2014) Dhong Hyun Lee et al. INTERNATIONAL JOURNAL OF CANCER
- Structure of the DDB1–CRBN E3 ubiquitin ligase in complex with thalidomide
- (2014) Eric S. Fischer et al. NATURE
- deepTools: a flexible platform for exploring deep-sequencing data
- (2014) Fidel Ramírez et al. NUCLEIC ACIDS RESEARCH
- Transcription Factor Cooperativity in Early Adipogenic Hotspots and Super-Enhancers
- (2014) Rasmus Siersbæk et al. Cell Reports
- Discovery and Characterization of Super-Enhancer-Associated Dependencies in Diffuse Large B Cell Lymphoma
- (2013) Bjoern Chapuy et al. CANCER CELL
- Selective Inhibition of Tumor Oncogenes by Disruption of Super-Enhancers
- (2013) Jakob Lovén et al. CELL
- Master Transcription Factors and Mediator Establish Super-Enhancers at Key Cell Identity Genes
- (2013) Warren A. Whyte et al. CELL
- Super-Enhancers in the Control of Cell Identity and Disease
- (2013) Denes Hnisz et al. CELL
- Phase II Trial of the CDK4 Inhibitor PD0332991 in Patients With Advanced CDK4-Amplified Well-Differentiated or Dedifferentiated Liposarcoma
- (2013) Mark A. Dickson et al. JOURNAL OF CLINICAL ONCOLOGY
- Mode of action of trabectedin in myxoid liposarcomas
- (2013) S Di Giandomenico et al. ONCOGENE
- Core Transcriptional Regulatory Circuit Controlled by the TAL1 Complex in Human T Cell Acute Lymphoblastic Leukemia
- (2012) Takaomi Sanda et al. CANCER CELL
- Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study
- (2012) Isabelle Ray-Coquard et al. LANCET ONCOLOGY
- Pleomorphic liposarcoma
- (2011) Markus P. Ghadimi et al. CANCER
- Snail2 is an Essential Mediator of Twist1-Induced Epithelial Mesenchymal Transition and Metastasis
- (2011) E. Casas et al. CANCER RESEARCH
- BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
- (2011) Jake E. Delmore et al. CELL
- Characterization of a new trabectedin-resistant myxoid liposarcoma cell line that shows collateral sensitivity to methylating agents
- (2011) S. Uboldi et al. INTERNATIONAL JOURNAL OF CANCER
- A public genome-scale lentiviral expression library of human ORFs
- (2011) Xiaoping Yang et al. NATURE METHODS
- Frequent Alterations and Epigenetic Silencing of Differentiation Pathway Genes in Structurally Rearranged Liposarcomas
- (2011) B. S. Taylor et al. Cancer Discovery
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- The NIH Roadmap Epigenomics Mapping Consortium
- (2010) Bradley E Bernstein et al. NATURE BIOTECHNOLOGY
- Subtype-specific genomic alterations define new targets for soft-tissue sarcoma therapy
- (2010) Jordi Barretina et al. NATURE GENETICS
- c‐Junamplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation programme
- (2009) Eric L Snyder et al. JOURNAL OF PATHOLOGY
- Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors
- (2009) C. Forni et al. MOLECULAR CANCER THERAPEUTICS
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line
- (2007) Fredrik Persson et al. CANCER LETTERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search